Computed tomography-guided percutaneous cryoablation of T1b renal tumors: safety, functional and oncological outcomes

References

• Zini L, Perrotte P, Capitanio U, et al. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer. 2009;115(7):1465–1471.
   PubMed Web of Science ®Google Scholar
• Huang WC, Elkin EB, Levey AS, et al. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors – is there a difference in mortality and cardiovascular outcomes? J Urol. 2009;181(1):55–62.
   PubMed Web of Science ®Google Scholar
• Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198(3):520–529.
   PubMed Web of Science ®Google Scholar
• Hasegawa T, Yamanaka T, Gobara H, et al. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study. Jpn J Radiol. 2018;36(9):551–558.
   PubMed Web of Science ®Google Scholar
• Zagoria RJ, Traver MA, Werle DM, et al. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. Am J Roentgenol. 2007;189(2):429–436.
   PubMed Web of Science ®Google Scholar
• Okhunov Z, Chamberlin J, Moreira DM, et al. Salvage percutaneous cryoablation for locally recurrent renal-cell carcinoma after primary cryoablation. J Endourol. 2016;30(6):632–637.
   PubMed Web of Science ®Google Scholar
• Aoun HD, Littrup PJ, Jaber M, et al. Percutaneous cryoablation of renal tumors: is it time for a new paradigm shift? J Vasc Interv Radiol. 2017;28(10):1363–1370.
   PubMed Web of Science ®Google Scholar
• Thompson RH, Atwell T, Schmit G, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015;67(2):252–259.
   PubMed Web of Science ®Google Scholar
• Hebbadj S, Cazzato RL, Garnon J, et al. Safety considerations and local tumor control following percutaneous image-guided cryoablation of T1b renal tumors. Cardiovasc Intervent Radiol. 2018;41(3):449–458.
   PubMed Web of Science ®Google Scholar
• Gunn AJ, Joe WB, Salei A, et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: safety, technical results, and clinical outcomes. Cardiovasc Intervent Radiol. 2019;42(7):970–978.
   PubMed Web of Science ®Google Scholar
• Breen DJ, King AJ, Patel N, et al. Image-guided cryoablation for sporadic renal cell carcinoma: three- and 5-year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology. 2018;289(2):554–561.
   PubMed Web of Science ®Google Scholar
• Parsons RB, Canter D, Kutikov A, et al. RENAL nephrometry scoring system: the radiologist’s perspective. Am J Roentgenol. 2012;199(3):W355–W359.
   PubMed Web of Science ®Google Scholar
• Ahmed M. Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update: supplement to the consensus document. J Vasc Interv Radiol. 2014;25(11):1706–1708.
   PubMed Web of Science ®Google Scholar
• Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213.
   PubMed Web of Science ®Google Scholar
• Caputo PA, Zargar H, Ramirez D, et al. Cryoablation versus partial nephrectomy for clinical T1b renal tumors: a matched group comparative analysis. Eur Urol. 2017;71(1):111–117.
   PubMed Web of Science ®Google Scholar
• Petros FG, Matin SF. Cryoablation for cT1b renal tumors? Yet to be determined. Eur Urol. 2017;71(1):118–119.
   PubMed Web of Science ®Google Scholar
• Gravis G, Faure M, Rybikowski S, et al. Radiation therapy following targeted therapy in oligometastatic renal cell carcinoma. Mol Clin Oncol. 2015;3(6):1248–1250.
   PubMed Web of Science ®Google Scholar
• Lu X, Gu W, Zhang H, et al. Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib. Oncotarget. 2016;7:26879–26887.
   PubMedGoogle Scholar
• Atwell TD, Vlaminck JJ, Boorjian SA, et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. J Vasc Interv Radiol. 2015;26(6):792–799.
   PubMed Web of Science ®Google Scholar
• Miller JM, Julien P, Wachsman A, et al. The role of embolization in reducing the complications of cryoablation in renal cell carcinoma. Clin Radiol. 2014;69(10):1045–1049.
   PubMed Web of Science ®Google Scholar
• Kakarala B, Frangakis CE, Rodriguez R, et al. Hemorrhagic complications of percutaneous cryoablation for renal tumors: results from a 7-year prospective study. Cardiovasc Intervent Radiol. 2016;39(11):1604–1610.
   PubMed Web of Science ®Google Scholar
• Rosenberg MD, Kim CY, Tsivian M, et al. Percutaneous cryoablation of renal lesions with radiographic ice ball involvement of the renal sinus: analysis of hemorrhagic and collecting system complications. Am J Roentgenol. 2011;196(4):935–939.
   PubMed Web of Science ®Google Scholar
• Warlick CA, Lima GC, Allaf ME, et al. Clinical sequelae of radiographic iceball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablation. Urology. 2006;67(5):918–922.
   PubMed Web of Science ®Google Scholar
• Tanagho YS, Kaouk JH, Allaf ME, et al. Perioperative complications of robot-assisted partial nephrectomy: analysis of 886 patients at 5 United States centers. Urology. 2013;81(3):573–579.
   PubMed Web of Science ®Google Scholar
• Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305.
   PubMed Web of Science ®Google Scholar
• Rivero JR, De La Cerda J, Wang H, et al. Partial nephrectomy versus thermal ablation for clinical stage T1 renal masses: systematic review and meta-analysis of more than 3,900 patients. J Vasc Interv Radiol. 2018;29(1):18–29.
   PubMed Web of Science ®Google Scholar
• Pierorazio PM, Johnson MH, Patel HD, et al. Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol. 2016;196(4):989–999.
   PubMed Web of Science ®Google Scholar
• Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imag. 1996;6(1):162–166.
   PubMed Web of Science ®Google Scholar